140 related articles for article (PubMed ID: 25582955)
1. The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Dores-Sousa JL; Duarte JA; Seabra V; Bastos Mde L; Carvalho F; Costa VM
Toxicology; 2015 Mar; 329():106-19. PubMed ID: 25582955
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
[TBL] [Abstract][Full Text] [Related]
3. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity.
Rossato LG; Costa VM; de Pinho PG; Arbo MD; de Freitas V; Vilain L; de Lourdes Bastos M; Palmeira C; Remião F
Arch Toxicol; 2013 Oct; 87(10):1809-20. PubMed ID: 23545721
[TBL] [Abstract][Full Text] [Related]
4. Subchronic administration of mitoxantrone and the influence of enzyme inhibitors on its induced cardiotoxicity in mice: role of NRF-2/CYP2E1.
Emeka PM; Ibrahim HIM; Alhaider IA; Morsy MA; Mohamed ME
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7806-7822. PubMed ID: 34982442
[TBL] [Abstract][Full Text] [Related]
5. Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity.
Anghel N; Cotoraci C; Ivan A; Suciu M; Herman H; Balta C; Nicolescu L; Olariu T; Galajda Z; Ardelean A; Hermenean A
Histol Histopathol; 2015 Dec; 30(12):1465-75. PubMed ID: 26112963
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
7. Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model.
Desai VG; Herman EH; Moland CL; Branham WS; Lewis SM; Davis KJ; George NI; Lee T; Kerr S; Fuscoe JC
Toxicol Appl Pharmacol; 2013 Jan; 266(1):109-21. PubMed ID: 23142469
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Costa VM; Capela JP; Sousa JR; Eleutério RP; Rodrigues PRS; Dores-Sousa JL; Carvalho RA; Lourdes Bastos M; Duarte JA; Remião F; Almeida MG; Varner KJ; Carvalho F
Arch Toxicol; 2020 Dec; 94(12):4067-4084. PubMed ID: 32894303
[TBL] [Abstract][Full Text] [Related]
9. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
[TBL] [Abstract][Full Text] [Related]
10. 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation.
El-Bakly WM; Louka ML; El-Halawany AM; Schaalan MF
Cancer Chemother Pharmacol; 2012 Dec; 70(6):833-41. PubMed ID: 23014738
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity.
Ahmed F; Urooj A
Pharm Biol; 2012 Apr; 50(4):468-73. PubMed ID: 22136326
[TBL] [Abstract][Full Text] [Related]
12. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
Elberry AA; Abdel-Naim AB; Abdel-Sattar EA; Nagy AA; Mosli HA; Mohamadin AM; Ashour OM
Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931
[TBL] [Abstract][Full Text] [Related]
13. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
[TBL] [Abstract][Full Text] [Related]
14. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
16. Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Dinis-Oliveira RJ; Santos-Silva A; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):254-62. PubMed ID: 24119282
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine offers cardioprotection by decreasing cardiac lipid hydroperoxides and 8-isoprostane level in isoproterenol-induced cardiotoxicity in rats.
Haleagrahara N; Julian V; Chakravarthi S
Cardiovasc Toxicol; 2011 Dec; 11(4):373-81. PubMed ID: 21796404
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.
Rossato LG; Costa VM; Vilas-Boas V; de Lourdes Bastos M; Rolo A; Palmeira C; Remião F
Cardiovasc Toxicol; 2013 Dec; 13(4):413-25. PubMed ID: 24046265
[TBL] [Abstract][Full Text] [Related]
19. Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
Shipp NG; Dorr RT; Alberts DS; Dawson BV; Hendrix M
Cancer Res; 1993 Feb; 53(3):550-6. PubMed ID: 8425187
[TBL] [Abstract][Full Text] [Related]
20. Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development.
Engle SK; Jordan WH; Pritt ML; Chiang AY; Davis MA; Zimmermann JL; Rudmann DG; Heinz-Taheny KM; Irizarry AR; Yamamoto Y; Mendel D; Schultze AE; Cornwell PD; Watson DE
Toxicol Pathol; 2009 Aug; 37(5):617-28. PubMed ID: 19549929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]